NCT05646836
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05646836
Title A Study to Evaluate the Safety, Pharmacokinetics, and Activity of XmAb24306 in Combination With Cevostamab in Participants With Relapsed/Refractory Multiple Myeloma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genentech, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries NOR | ISR | GRC | ESP | DNK | AUS

Facility Status City State Zip Country Details
Royal Adelaide Hospital Adelaide South Australia 5000 Australia Details
Peter Maccallum Cancer Centre Melbourne Victoria 3000 Australia Details
Alfred Hospital Melbourne Victoria 3004 Australia Details
Sygehus Lillebaelt - Vejle Sygehus Vejle 7100 Denmark Details
Evangelismos General Hospital of Athens Athens 106 76 Greece Details
University of Athens, Hematological Clinic, Athens 115 28 Greece Details
Rabin Medical Center-Beilinson Campus Petah Tikva 4941492 Israel Details
Tel Aviv Sourasky Medical Center PPDS Tel Aviv 64239 Israel Details
Oslo University Hospital Rikshospitalet Oslo N - 0424 Norway Details
Severance Hospital, Yonsei University Seoul 03722 South Korea Details
Asan Medical Center - PPDS Seoul 05505 South Korea Details
Clinica Universidad de Navarra Pamplona Navarre 31008 Spain Details
Hospital Universitari i Politecnic La Fe de Valencia Valencia 46026 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field